Cocrystal Pharma Insider Buying Surge Signals Confidence Ahead of Norovirus Data Reveal
Insider buying spurs confidence in Cocrystal Pharma (CRP) as executives accumulate shares ahead of key norovirus data, suggesting a potential upside for investors.
3 minutes to read
